HPV can be detected in men, but not through a routine screening test the way it can in women. There is no FDA-approved HPV test for general use in men as of 2026, which means most men with HPV never receive a formal diagnosis unless visible symptoms appear or they fall into a specific high-risk group that warrants targeted testing.
That gap in testing doesn’t mean HPV is rare in men. It’s actually very common. Understanding why routine detection isn’t standard, and what options do exist, is what this page covers.
Key Takeaways
- No FDA-approved routine HPV screening test exists for men as of 2026.
- Visual examination remains the primary way HPV is identified in men with symptoms.
- Anal Pap smears and anal HPV DNA testing are used in selected high-risk men, not as universal screening.
- Most HPV infections in men clear on their own, but some types carry real cancer risks.
- Vaccination is the most effective tool available, and it works even if you’ve already been exposed to some HPV types.
Why There’s No Routine HPV Test for Men
HPV is extremely common. Most sexually active adults will have it at some point. In women, cervical HPV testing is well-established because the cervix provides a consistent, accessible sampling site, and the link between persistent high-risk HPV and cervical cancer is direct and well-documented.
Men don’t have an equivalent anatomical site. HPV DNA has been detected on the penile shaft, glans, foreskin, scrotum, perianal skin, and urethra, but no single location provides a reliable, standardized sample the way a cervical swab does. Sampling is technically inconsistent, and studies show that HPV can be present on one area while absent on another, sampled minutes apart.
There’s also a clinical reasoning issue: even when HPV is detected in men, there’s currently no established treatment protocol tied to that result. A positive finding doesn’t change clinical management the way it does in women, where it triggers colposcopy or closer monitoring intervals. Without a clear next step, routine screening doesn’t meet the threshold for a population-wide recommendation.
The CDC and other major health bodies have not endorsed routine HPV testing for men, and that position hasn’t changed heading into 2026.
How Can HPV be Detected in Men in Clinical Practice?
Despite the absence of a routine screening test, HPV is identified in men through several approaches, each with specific indications.
Visual Examination
The most common method. Genital warts caused by low-risk HPV types 6 and 11 are diagnosed by appearance. A clinician examines the penis, scrotum, perianal area, and sometimes the urethra. No lab test is required for a straightforward wart diagnosis. The HPV symptoms guide covering signs in men and women explains what these look like and why most HPV infections produce no visible signs at all.
Anal Pap Smear and Anal HPV DNA Testing
This is the most clinically validated detection method available for men. It works the same way a cervical Pap smear does, a swab collects cells from the anal canal, which are then examined for abnormal changes or tested for HPV DNA.
Anal HPV testing is recommended for men who have sex with men (MSM), men living with HIV, and other immunocompromised individuals, groups where the risk of anal dysplasia and anal cancer is meaningfully elevated. It is not recommended for the general male population. The anal HPV test guide covers what to expect from the procedure and how results are interpreted.
Urine-Based HPV DNA Testing
Commercial urine-based HPV DNA tests for men have emerged in recent years. These tests can detect HPV genetic material in urine samples and have shown some promise in research settings. However, as of 2026, they remain outside formal clinical screening guidelines. Sensitivity varies, and no regulatory body has approved them as a standard diagnostic tool for men. They are not equivalent to the cervical HPV tests used in women.
Experimental Approaches
Urethral swabs and penile swabs have been studied in research contexts and can detect HPV DNA. These approaches have demonstrated technical feasibility but have never become standard care. They are not available as routine clinical tests.
Who’s at Higher Risk for HPV-Related Complications in Men?
Most men with HPV clear the infection without ever knowing they had it. But certain groups face a meaningfully higher risk of persistent infection or HPV-related cancer:
- Men who have sex with men (MSM): Significantly higher rates of anal HPV infection and anal cancer compared to the general male population.
- Men living with HIV or other immunocompromising conditions: The immune system plays a central role in clearing HPV. Organ transplant recipients and others on immunosuppressive therapy are also in this category.
- Unvaccinated men: HPV types 16 and 18, the two types responsible for the majority of HPV-related cancers, are preventable with vaccination. Unvaccinated men remain fully susceptible.
- Men with a history of multiple sexual partners or early sexual activity: Higher cumulative exposure increases the likelihood of encountering high-risk HPV genotypes.
What HPV-Related Cancers Can Affect Men?
HPV doesn’t only cause genital warts. High-risk types, primarily HPV 16 and 18, are linked to several cancers that affect men directly. These include penile cancer, anal cancer, and oropharyngeal cancer (cancers of the throat, base of the tongue, and tonsils). Oropharyngeal cancer rates in men have been rising, and HPV is now the leading cause of this cancer type in the United States.
The HPV and cancer overview covers which cancer types are linked, how the progression works, and what early detection looks like for each.
Most men with high-risk HPV will not develop cancer. The infection clears. But “most” is not “all,” and persistent infection with a high-risk type is what creates real risk over time.
At-Home HPV Tests for Men: What’s Available?
No validated at-home HPV self-test for men has been approved as of mid-2026. Some direct-to-consumer products have appeared online, but none have regulatory approval or validated clinical accuracy for male HPV detection. The HPV testing guide explains how approved HPV tests work, who they’re designed for, and how to read results, which is useful context for understanding why male testing remains more limited.
What Men Can Actually Do About HPV
The absence of a routine test doesn’t mean there’s nothing to do. There are clear, evidence-based steps.
Get vaccinated if you haven’t already. The HPV vaccine covers the high-risk types most likely to cause cancer and the low-risk types that cause genital warts. It’s approved for men through age 45, and it provides protection even against types you haven’t yet been exposed to. The HPV vaccine for men guide addresses whether it’s still useful if you already have HPV, the answer is nuanced and worth reading.
Get anal Pap screening if you’re in a high-risk group. If you’re MSM, HIV-positive, or immunocompromised, ask your doctor about anal HPV screening. Cell changes are easiest to treat before they progress, that’s what screening is for.
See a clinician if you notice symptoms. Genital warts are treatable. Treatment options for genital warts range from topical prescription medications to in-office procedures, and most cases resolve with treatment.
Understand transmission honestly. If you’ve been diagnosed or a partner has, the timing of HPV infection is often unknowable. The guide on how HPV spreads explains transmission clearly, without the assumptions that often make these conversations harder than they need to be.
Frequently Asked Questions
Can a man find out his HPV status through a blood test?
No. There is no blood test that reliably detects active HPV infection in men. Antibody tests exist in research settings, but they don’t indicate current infection status and are not used clinically. The only way HPV is currently identified in men is through visual examination, anal Pap smear, or DNA testing of specific anatomical sites in high-risk individuals.
If my partner tested positive for HPV, does that mean I have it too?
Possibly, but not necessarily. HPV transmission between partners is common, but it’s not guaranteed. More importantly, even if you were exposed, your immune system may have already cleared it. There’s currently no reliable way to test a man’s general HPV status to answer this question definitively.
Does HPV in men always cause symptoms?
No. Most men with HPV have no symptoms at all. The infection is often transient and clears without causing warts, cell changes, or any noticeable sign. That’s one reason HPV spreads so easily, most people carrying it don’t know.
Is there any point in a man asking his doctor about HPV testing?
Yes, depending on your situation. If you’re in a high-risk group, MSM, HIV-positive, immunocompromised, anal HPV screening is clinically relevant and worth discussing. If you have visible symptoms, a clinical exam is the right first step. For men outside those groups, a conversation with your doctor about vaccination status and cancer risk is still worthwhile, even without a formal screening test available.
Will routine HPV testing for men become available in the future?
Research is ongoing. Improved sampling methods, urine-based testing, and more targeted approaches are being studied. But as of 2026, no major health body has announced an imminent shift in policy toward routine male HPV screening. The evidence base needed to justify population-wide testing, including proof that detection changes outcomes, hasn’t yet been established.
